Pharmacogenetic profile of xenobiotic enzyme metabolism in survivors of the Spanish toxic oil syndrome

Environmental Health Perspectives
M G LadonaE J Sanz

Abstract

In 1981, the Spanish toxic oil syndrome (TOS) affected more than 20,000 people, and over 300 deaths were registered. Assessment of genetic polymorphisms on xenobiotic metabolism would indicate the potential metabolic capacity of the victims at the time of the disaster. Thus, impaired metabolic pathways may have contributed to the clearance of the toxicant(s) leading to a low detoxification or accumulation of toxic metabolites contributing to the disease. We conducted a matched case-control study using 72 cases (54 females, 18 males) registered in the Official Census of Affected Patients maintained by the Spanish government. Controls were nonaffected siblings (n =72) living in the same household in 1981 and nonaffected nonrelatives (n = 70) living in the neighborhood at that time, with no ties to TOS. Genotype analyses were performed to assess the metabolic capacity of phase I [cytochrome P450 1A1 (CYP1A1), CYP2D6] and phase II [arylamine N-acetyltransferase-2 (NAT2), GSTM1 (glutathione S-transferase M1) and GSTT1] enzyme polymorphisms. The degree of association of the five metabolic pathways was estimated by calculating their odds ratios (ORs) using conditional logistic regression analysis. In the final model, cases compared wi...Continue Reading

References

Jun 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·M BlumU A Meyer
Aug 8, 1991·Biochemical Pharmacology·D Hickman, E Sim
Jul 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·R C SkodaU A Meyer
Oct 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·J SeidegårdW R Pearson
Jun 1, 1988·American Journal of Epidemiology·E M KilbourneM M Zack
May 1, 1987·American Journal of Epidemiology·F Diaz de RojasJ M Tabuenca Oliver
Mar 1, 1966·Biochemical Pharmacology·J M Stolk, R P Smith
Dec 1, 1967·The Journal of Pharmacy and Pharmacology·S McLeanJ Thomas
May 1, 1966·Biochemical Pharmacology·R M WelchJ J Burns
Feb 1, 1967·Biochemical Pharmacology·R P SmithP R Shafer
Oct 29, 1983·Lancet·A Vázquez RonceroE Graciani Constante
Feb 1, 1984·American Journal of Epidemiology·J G Rigau-PérezF Pérez-Gallardo
Aug 1, 1980·Naunyn-Schmiedeberg's Archives of Pharmacology·I RootsA G Hildebrandt
May 1, 1995·Toxicology Letters·E TaioliS J Garte
Feb 1, 1995·Archives of Environmental Contamination and Toxicology·R H HillJ R Barr
Apr 1, 1994·Clinical Pharmacology and Therapeutics·J A AgúndezJ Benítez
Jan 1, 1994·Epidemiologic Reviews·D M DwyerH K Armenian
Jan 1, 1994·Epidemiologic Reviews·T Lasky, P D Stolley
Jan 1, 1994·Epidemiologic Reviews·H AustinR S Greenberg
Nov 11, 1994·Toxicology·S GallardoP Palomino
Aug 1, 1994·Clinical Pharmacology and Therapeutics·J A AgúndezJ Benítez
Sep 1, 1993·Carcinogenesis·F CroftsS J Garte
Sep 1, 1993·Clinical Pharmacology and Therapeutics·W Kalow
Jan 19, 1996·Cancer Letters·M G LadonaJ Benítez
Mar 1, 1996·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·M Posada de la PazE M Kilbourne
Jun 1, 1996·Pharmacogenetics·A K DalyU M Zanger
Sep 1, 1996·Chemical Research in Toxicology·H H SchurzL L Needham
Jan 1, 1997·Archives of Toxicology. Supplement. = Archiv Für Toxikologie. Supplement·A Gómez de la CámaraM Posada de la Paz
Jan 1, 1997·Archives of Toxicology. Supplement. = Archiv Für Toxikologie. Supplement·R M PhilenE M Kilbourne
Apr 1, 1997·Pharmacogenetics·R LøvlieV M Steen
Jan 23, 1998·Forensic Science International : Synergy·I M Sebetan, H A Hajar
Apr 16, 1998·Immunology·T KawaiM A Taubman
Apr 16, 1998·Immunology Today·P GriemE Gleichmann
May 7, 1998·Toxicology·B R BlakleyM Fournier
Oct 8, 1998·Journal of Clinical Epidemiology·A Gómez de la CámaraB Terracini
Feb 19, 1999·International Journal of Epidemiology·I Abaitua BordaE M Kilbourne

❮ Previous
Next ❯

Citations

May 11, 2002·Environmental Health Perspectives·Emilio GelpíUNKNOWN WHO/CISAT Scientific Committee for the Toxic Oil Syndrome. Centro de Investigación para el Síndrome del Aceite Tóxico
Aug 15, 2002·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·G C Hard
Jan 13, 2010·Shokuhin eiseigaku zasshi. Journal of the Food Hygienic Society of Japan·Tamio Maitani, Hiroshi Saitoh
Dec 31, 2002·Toxicology Letters·Amy R WeatherillJean A Hall
Oct 30, 2008·Journal of Immunotoxicology·Rachel Patterson, Dori Germolec
Nov 16, 2010·Chemico-biological Interactions·Carmen QueroJoaquin Abian
Jan 22, 2008·European Journal of Internal Medicine·María Luisa García de AguinagaFrancisco Javier Barbado Hernández
Oct 21, 2005·Toxicology Letters·Blanca CárdabaCarlos Lahoz
Apr 6, 2004·Clinics in Chest Medicine·Tim HigenbottamMohamed Essener
Jan 30, 2002·Environmental Health Perspectives·Floyd FrostKenneth G Brown
Jan 30, 2002·Environmental Health Perspectives·Daniel Wartenberg, Cheryl Siegel Scott
Jan 30, 2002·Environmental Health Perspectives·José M Ladero
Jan 30, 2002·Environmental Health Perspectives·Daniel W NebertMichael J Carvan
Jan 22, 2002·The American Journal of Dermatopathology·S E CowperP E LeBoit

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Epidemiology
I Abaitua BordaE M Kilbourne
Environmental Health Perspectives
Emilio GelpiWHO/CISAT Scientific Committee for the Toxic Oil Syndrome. Centro de Investigación para el Síndrome del Aceite Tóxico
Journal of Clinical Epidemiology
A Gómez de la CamaraB Terracini
© 2021 Meta ULC. All rights reserved